Induction Healthcare Group (INHC) Competitors

GBX 12.50
0.00 (0.00%)
(As of 05/17/2024 ET)

INHC vs. FDBK, COG, IQAI, RENX, KNB, IHC, PRM, IMM, SNG, and ABDX

Should you be buying Induction Healthcare Group stock or one of its competitors? The main competitors of Induction Healthcare Group include Feedback (FDBK), Cambridge Cognition (COG), IQ-AI (IQAI), Renalytix (RENX), Kanabo Group (KNB), Inspiration Healthcare Group (IHC), Proteome Sciences (PRM), ImmuPharma (IMM), Synairgen (SNG), and Abingdon Health (ABDX). These companies are all part of the "medical" sector.

Induction Healthcare Group vs.

Feedback (LON:FDBK) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

Feedback has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.38, indicating that its stock price is 138% less volatile than the S&P 500.

Feedback has a net margin of 0.00% compared to Feedback's net margin of -120.26%. Induction Healthcare Group's return on equity of -32.67% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
FeedbackN/A -32.67% -21.47%
Induction Healthcare Group -120.26%-47.42%-10.25%

Feedback has higher earnings, but lower revenue than Induction Healthcare Group. Feedback is trading at a lower price-to-earnings ratio than Induction Healthcare Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£1.02M9.61-£3.49M-£0.26-282.69
Induction Healthcare Group£11.82M0.98-£14.18M-£0.15-83.33

Feedback received 151 more outperform votes than Induction Healthcare Group when rated by MarketBeat users. However, 93.33% of users gave Induction Healthcare Group an outperform vote while only 67.07% of users gave Feedback an outperform vote.

CompanyUnderperformOutperform
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Feedback
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Induction Healthcare Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

52.8% of Feedback shares are held by institutional investors. Comparatively, 42.4% of Induction Healthcare Group shares are held by institutional investors. 11.0% of Feedback shares are held by company insiders. Comparatively, 46.7% of Induction Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Induction Healthcare Group had 4 more articles in the media than Feedback. MarketBeat recorded 4 mentions for Induction Healthcare Group and 0 mentions for Feedback. Induction Healthcare Group's average media sentiment score of 0.67 beat Feedback's score of 0.56 indicating that Feedback is being referred to more favorably in the media.

Company Overall Sentiment
Feedback Positive
Induction Healthcare Group Positive

Summary

Feedback beats Induction Healthcare Group on 8 of the 15 factors compared between the two stocks.

Get Induction Healthcare Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for INHC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INHC vs. The Competition

MetricInduction Healthcare GroupHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£11.55M£254.86M£5.24B£1.73B
Dividend YieldN/A6.26%44.24%6.70%
P/E Ratio-83.33494.42100.501,971.20
Price / Sales0.98685.002,370.72383,164.31
Price / Cash2.6845.4636.7926.98
Price / Book0.505.885.492.95
Net Income-£14.18M-£5.71M£105.95M£172.89M
7 Day PerformanceN/A-0.34%1.42%0.85%
1 Month PerformanceN/A1.68%4.96%28.79%
1 Year Performance-44.44%-5.19%7.84%11.50%

Induction Healthcare Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
0 of 5 stars
GBX 74
-1.3%
N/A-38.0%£9.86M£1.02M-284.6224Gap Down
COG
Cambridge Cognition
0 of 5 stars
GBX 47.50
-1.0%
N/A-55.0%£16.70M£12.77M-475.0080
IQAI
IQ-AI
0 of 5 stars
GBX 1.55
flat
N/A-46.2%£3.44M£538,190.00-13.676News Coverage
RENX
Renalytix
0 of 5 stars
GBX 23.50
-4.1%
N/A-73.0%£34.67M£2.41M-65.28102Gap Down
KNB
Kanabo Group
0 of 5 stars
GBX 1.73
-1.1%
N/A-39.5%£10.94M£1,000.00-173.0023Gap Up
IHC
Inspiration Healthcare Group
0 of 5 stars
GBX 15.71
-2.4%
N/A-64.7%£10.72M£41.08M-1,570.80210Positive News
High Trading Volume
PRM
Proteome Sciences
0 of 5 stars
GBX 3.51
-1.1%
N/A-20.0%£10.36M£5.03M-351.0029News Coverage
Gap Down
IMM
ImmuPharma
0 of 5 stars
GBX 2.39
+0.4%
N/A-28.2%£9.95M£94,819.00-239.0013Gap Down
SNG
Synairgen
0 of 5 stars
GBX 6.16
+0.0%
N/A-26.4%£12.41M£79,000.00-123.2434News Coverage
Gap Up
ABDX
Abingdon Health
0 of 5 stars
GBX 10.40
+6.7%
N/A+31.5%£12.66M£5.34M-1,040.0084Gap Up

Related Companies and Tools

This page (LON:INHC) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners